부산대학교 도서관

Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Tuazon SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington.; Pont MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Translational Sciences, Galapagos NV, Mechelen, Belgium.; Cole GO; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Translational Sciences, Galapagos NV, Mechelen, Belgium.; Sather BD; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Research, Tune Therapeutics, Seattle, Washington.; Song X; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Thomas S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Wood BL; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California.; Blake M; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Translational Sciences, Sonoma Biotherapeutics, Seattle, Washington.; Works MG; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Therapeutic Pipeline, AltPep, Seattle, Washington.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Wu VQ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Cancer Immunotherapy, The University of Sydney, Camperdown, New South Wales, Australia; Haematology and Transfusion Medicine, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Coffey DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Translational Research, Sylvester Comprehensive Cancer Center, Miami, Florida; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Libby EN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Chapuis AG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Translational Research, Sylvester Comprehensive Cancer Center, Miami, Florida; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida. Electronic address: damiangreen@miami.edu.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

JM Specht; SM Lee; C Turtle; C Berger; A Balakrishnan; S Srivastava; V Viollet; J Veatch; T Gooley; E Mullane; CN Chaney; C Rader; RH Pierce; R Gottardo; DG Maloney; SR Riddell

Cancer Research. 79:P2-09

Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX.; Chavez JC; Moffitt Cancer Center, Tampa, FL.; Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA.; Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Ulrickson ML; Banner MD Anderson Cancer Center, Gilbert, AZ.; Bachy E; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; Munshi PN; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Casulo C; University of Rochester Medical Center, Wilmot Cancer Center, Rochester, NY.; Maloney DG; Fred Hutchinson Cancer Center, Seattle, WA.; de Vos S; Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA.; Reshef R; Columbia University Herbert Irving Comprehensive Cancer Center, New York City, NY.; Leslie LA; John Theurer Cancer Center, Hackensack, NJ.; Oluwole OO; Vanderbilt University Medical Center, Nashville, TN.; Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France.; Khanal R; Fox Chase Cancer Center, Philadelphia, PA.; Rosenblatt JD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL.; Wulff J; Kite, a Gilead Company, Santa Monica, CA.; Shen RR; Kite, a Gilead Company, Santa Monica, CA.; Zhang W; Kite, a Gilead Company, Santa Monica, CA.; Poddar S; Kite, a Gilead Company, Santa Monica, CA.; Miao H; Kite, a Gilead Company, Santa Monica, CA.; Nikolajeva O; Kite, a Gilead Company, Santa Monica, CA.; Jacobson CA; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Locke FL; Moffitt Cancer Center, Tampa, Florida. Electronic address: Frederick.locke@moffitt.org.; Nikiforow S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Frigault MJ; Massachusetts General Hospital, Boston, Massachusetts.; Maloney DG; Fred Hutchinson Cancer Center, Seattle, Washington.; Davila M; Roswell Park, Buffalo, New York.; Miklos DB; Stanford University, Stanford, California.; Lin Y; Mayo Clinic, Rochester, Minnesota.; Vong J; A2 Biotherapeutics, Inc., Agoura Hills, California.; Shah NN; Medical College of Wisconsin, Milwaukee, Wisconsin.; Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Welch J; A2 Biotherapeutics, Inc., Agoura Hills, California.; Ng E; A2 Biotherapeutics, Inc., Agoura Hills, California.; Jacobson C; Dana-Farber Cancer Institute, Boston, Massachusetts.; Maus MV; Massachusetts General Hospital, Boston, Massachusetts.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Portuguese AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA. aportugu@fredhutch.org.; Huang JJ; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Jeon Y; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Taheri M; Washington State University, Pullman, WA.; Albittar A; University of Washington, Seattle, WA, USA; MD Anderson Cancer Center, Houston, TX.; Liang EC; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Hirayama AV; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Kimble EL; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Iovino L; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Poh C; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Gopal AK; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Shadman M; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Till BG; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Milano F; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Chapuis AG; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Otegbeye F; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Cassaday RD; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Basom RS; Fred Hutchinson Cancer Center, Seattle, WA.; Wu QV; Fred Hutchinson Cancer Center, Seattle, WA.; Maloney DG; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.; Gauthier J; Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, WA.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Tuazon SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Pont MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cole GO; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Sather BD; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Song X; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Thomas S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Wood BL; Hematopathology Division, University of Washington, Seattle, WA.; Blake M; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Works MG; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Wu QV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Coffey DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami, Miami, FL.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Lozac'hmeur A; Tempus AI Inc., Chicago, IL, USA.; Danek T; Tempus AI Inc., Chicago, IL, USA.; Yang Q; Tempus AI Inc., Chicago, IL, USA.; Rosasco MG; Tempus AI Inc., Chicago, IL, USA.; Welch JS; A2 Biotherapeutics, Agoura Hills, CA, USA.; Go WY; A2 Biotherapeutics, Agoura Hills, CA, USA.; Ng EW; A2 Biotherapeutics, Agoura Hills, CA, USA.; Mardiros A; A2 Biotherapeutics, Agoura Hills, CA, USA.; Maloney DG; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Garon EB; David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Kirtane K; Moffitt Cancer Center, Tampa, FL, USA.; Simeone DM; Moores Cancer Center, UC San Diego Health, San Diego, CA, USA.; Molina JR; Mayo Clinic, Rochester, MN, USA.; Salahudeen AA; University of Illinois at Chicago College of Medicine, Departments of Medicine, Biochemistry & Molecular Genetics, Chicago, IL, USA.; Stein MM; Tempus AI Inc., Chicago, IL, USA. publications@tempus.com.; Hecht JR; David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Pullarkat S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Black G; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Bleakley M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America.; Buenrostro D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America.; Chapuis AG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Jaeger-Ruckstuhl CA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Kimble EL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Lee BM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Maloney DG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Radich J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Seaton BW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Specht JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Turtle CJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.; Woolston DW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Wright JH; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Program in Immunology, University of Washington, Seattle, Washington, United States of America.; Yeung CCS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Samples L; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Sadrzadeh H; Section of Hematology and Medical Oncology, Boston University Medical Center, Boston, MA.; Frigault MJ; Center for Cellular Immunotherapy, Massachusetts General Hospital, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hamadani M; Blood and Marrow Transplant and Cellular Therapy, Medical College of Wisconsin, Milwaukee, WI.; Gurumurthi A; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Medical Center, Houston, TX.; Strati P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Medical Center, Houston, TX.; Shouval R; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Noy A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Riedell PA; Section of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL.; Dahiya S; Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Center, Stanford, CA.; Maloney DG; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Till BG; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Hirayama AV; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gauthier J; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gopal AK; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Smith SD; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Poh C; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Lynch R; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Ujjani C; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Di M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Raghunathan V; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Shakib-Azar M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Naresh KN; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gooley TA; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Yared J; Division of Hematology/Oncology, University of Maryland, Baltimore, MD.; Jain MD; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Locke FL; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Leslie LA; Division of Lymphoma, John Theurer Cancer Center, Hackensack, NJ.; Epperla N; Division of Hematology, The Ohio State University, Columbus, OH.; Ghosh M; Bone Marrow Transplant and Leukemia, University of Michigan, Ann Arbor, MI.; Skarbnik A; Department of Hematology, Novant Health Cancer Institute, Charlotte, NC.; Hill BT; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.; Kamdar MK; Division of Hematology, University of Colorado Hospital, Aurora, CO.; Ortiz-Maldonado V; Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Martinez-Cibrian N; Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS.; Shadman M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Kampouri E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Ibrahimi SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Xie H; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Wong ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Hecht JB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Sekhon MK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Vo A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Stevens-Ayers TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Green DJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Perez A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Leisenring WM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Boeckh MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Hill JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Connelly-Smith L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Huang JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kimble EL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Fiorenza S; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Wu QV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Jaeger-Ruckstuhl CA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Pender BS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kirchmeier DR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Torkelson A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Braathen K; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Basom R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kopmar NE; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Bar M; Sandmaier BM; Inamoto Y; BRUNO, Benedetto; Hari P; Chauncey T; Martin PJ; Storb R; Maloney DG; Storer B; Flowers ME

Biology of Blood and Marrow Transplantation. 19:949-957

Hirayama AV; Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA.; Department of Medicine University of Washington Seattle Washington USA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Wright JH; Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA.; Smythe KS; Translational Science and Therapeutics Division Fred Hutchinson Cancer Center Seattle Washington USA.; Fiorenza S; Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA.; Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia.; Shaw AN; Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia.; Gauthier J; Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA.; Department of Medicine University of Washington Seattle Washington USA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Maloney DG; Department of Medicine University of Washington Seattle Washington USA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Translational Science and Therapeutics Division Fred Hutchinson Cancer Center Seattle Washington USA.; Naresh KN; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Translational Science and Therapeutics Division Fred Hutchinson Cancer Center Seattle Washington USA.; Department of Laboratory Medicine and Pathology University of Washington Seattle Washington USA.; Yeung CCS; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Translational Science and Therapeutics Division Fred Hutchinson Cancer Center Seattle Washington USA.; Department of Laboratory Medicine and Pathology University of Washington Seattle Washington USA.; Turtle CJ; Department of Medicine University of Washington Seattle Washington USA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center Seattle Washington USA.; Translational Science and Therapeutics Division Fred Hutchinson Cancer Center Seattle Washington USA.; Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

KIMBY E; TREON SP; ANAGNOSTOPOULOS A; DIMOPOULOS M; GARCIA SANZ R; GERTZ MA; JOHNSON S; LEBLOND V; FERMAND JP; MALONEY DG; MOREL P; MORRA E; NICHOLS G; OCIO EM; OWEN R; STONE M; BLADE J.; MERLINI, GIAMPAOLO

Clinical Lymphoma and Myeloma. 6:380-383

BARON F; STORB R; STORER BE; MARIS MB; NIEDERWIESER D; SHIZURU JA; CHAUNCEY, TR; BRUNO, Benedetto; FORMAN SJ; MCSWEENEY PA; MAZIARZ RT; PULSIPHER MA; AGURA ED; WADE, J; SORROR M; MALONEY DG; SANDMAIER BM

Journal of Clinical Oncology. 24:4150-4157

Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M; McSweeney P; Radich JP; Bredeson C; BRUNO, Benedetto; Langston A; Laken MR; Al Ali H; Blume KG; Storb R; Maloney DG

Journal of Clinical Oncology. 23:3819-3829

Bachanova, V; Burns, LJ; Wang, T; Carreras, J; Gale, RP; Wiernik, PH; Ballen, KK; Wirk, B; Munker, R; Rizzieri, DA; Chen, Y-B; Gibson, J; Akpek, G; Costa, LJ; Kamble, RT; Aljurf, MD; Hsu, JW; Cairo, MS; Schouten, HC; Bacher, U; Savani, BN; Wingard, JR; Lazarus, HM; Laport, GG; Montoto, S; Maloney, DG; Smith, SM; Brunstein, C; Saber, W

Bone Marrow Transplant

Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Huang JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Ortiz-Maldonado V; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Hematology, Hospital Clinic of Barcelona, Barcelona, Spain.; Albittar A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Wuliji N; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Basom R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Jeon Y; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Wu Q; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Torkelson A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kirchmeier D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Chutnik A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Pender B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Sorror M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Hill JA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kopmar NE; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Banerjee R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Green D; Division of Transplantation and Cellular Therapy, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Poh C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kimble EL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Iovino L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Chapuis AG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Otegbeye F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Turtle CJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Jaeger-Ruckstuhl CA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Specht JM; Division of Hematology and Medical Oncology, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Voutsinas JM; Clinical Statistics Team, Fred Hutchinson Cancer Center, Seattle, Washington.; MacMillan HR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Wu QV; Clinical Statistics Team, Fred Hutchinson Cancer Center, Seattle, Washington.; Muhunthan V; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Berger C; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Pullarkat S; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Wright JH; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Yeung CCS; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Hyun TS; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Seaton B; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Aicher LD; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Song X; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington.; Pierce RH; Clinical Trials Pathology, Fred Hutchinson Cancer Center, Seattle, Washington.; Lo Y; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Cole GO; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Lee SM; Division of Hematology and Medical Oncology, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Maloney DG; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Medical Oncology, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Riddell SR; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Medical Oncology, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE